Cesca Therapeutics, Inc. (KOOL) Advancing the Practice of Cell Therapy for Regenerative Medicine
Cesca Therapeutics, Inc. (NASDAQ: KOOL) describes itself as being “engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine.” The company focuses on three markets: therapies, medical and diagnostic devices, and cell manufacturing and banking services. Most recently, the company’s CLIRST III trial was approved by the U.S Food and … Continue reading “Cesca Therapeutics, Inc. (KOOL) Advancing the Practice of Cell Therapy for Regenerative Medicine”







